Jade Biosciences (JBIO) Times Interest Earned (2021 - 2024)
Jade Biosciences (JBIO) reported Times Interest Earned of -$98.33 for Q2 2024, up 99.52% on a YoY basis from -$49.29 in Q3 2023, and up 98.8% quarter-over-quarter from -$8206.0 in Q1 2024.
Jade Biosciences (JBIO) Times Interest Earned (2021 - 2024) Analysis & Trends
Jade Biosciences has reported Times Interest Earned for 4 years, with the latest figure at -$98.33 in Q2 2024.
- For the quarter ending Q2 2024, Times Interest Earned rose 99.52% year-over-year to -$98.33; the trailing twelve-month figure through Mar 2025 stood at -$8134.2 (down 42.64% YoY), and the FY2023 full-year result was -$15831.0, down 11449.07% from the prior year.
- Times Interest Earned for Q2 2024 stood at -$98.33, up from -$8206.0 in the prior quarter.
- The five-year high for Times Interest Earned was $8268.0 in Q4 2021, with the low at -$20336.0 in Q2 2023.
- Historically, Times Interest Earned has averaged -$5594.0 across 4 years, with a median of -$2407.9 in 2022.
- Annual changes were most pronounced in 2023 — Times Interest Earned sank 898.9% — and 2024, when it jumped 99.52%.
- Jade Biosciences' Times Interest Earned stood at $8268.0 in 2021, then sank by 124.62% to -$2035.8 in 2022, then slumped by 898.9% to -$20336.0 in 2023, then jumped by 99.52% to -$98.33 in 2024.
- The last three Times Interest Earned figures came in at -$98.33 (Q2 2024), -$8206.0 (Q1 2024), and -$20336.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Jade Biosciences | 973.55 Mn | 973.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -98.33 |
| Mar 31, 2024 | -8,206.00 |
| Jun 30, 2023 | -20,336.00 |
| Mar 31, 2023 | -17,639.00 |
| Jun 30, 2022 | -2,035.83 |
| Dec 31, 2021 | 8,268.00 |
| Jun 30, 2021 | -1,924.67 |
| Mar 31, 2021 | -2,780.00 |